Paul Matteis's Stock Ratings

Stifel Analyst

Paul Matteis is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 01/31/2025

Overall Average Return

-11.4%

Smart Score

43.2%

Overall Average Return Percentile

17th

Number of Ratings

135
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Vertex Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (21 Ratings)
Forecasting The Future: 23 Analyst Projections For Vertex Pharmaceuticals
Where Sage Therapeutics Stands With Analysts
Where Sage Therapeutics Stands With Analysts
Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
The Latest Analyst Ratings For Biomarin Pharmaceutical
The Analyst Landscape: 29 Takes On Biomarin Pharmaceutical
Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
A Glimpse Into The Expert Outlook On Alkermes Through 9 Analysts
In-Depth Examination Of 29 Analyst Recommendations For Biomarin Pharmaceutical
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved